These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 8918487)

  • 1. Chemotherapy without irradiation--a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study.
    Balmaceda C; Heller G; Rosenblum M; Diez B; Villablanca JG; Kellie S; Maher P; Vlamis V; Walker RW; Leibel S; Finlay JL
    J Clin Oncol; 1996 Nov; 14(11):2908-15. PubMed ID: 8918487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary chemotherapy for intracranial nongerminomatous germ cell tumors: results of the second international CNS germ cell study group protocol.
    Kellie SJ; Boyce H; Dunkel IJ; Diez B; Rosenblum M; Brualdi L; Finlay JL
    J Clin Oncol; 2004 Mar; 22(5):846-53. PubMed ID: 14990640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of primary chemotherapy followed by reduced-dose radiation for CNS germ cell tumors.
    Buckner JC; Peethambaram PP; Smithson WA; Groover RV; Schomberg PJ; Kimmel DW; Raffel C; O'Fallon JR; Neglia J; Shaw EG
    J Clin Oncol; 1999 Mar; 17(3):933-40. PubMed ID: 10071287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive cisplatin and cyclophosphamide-based chemotherapy without radiotherapy for intracranial germinomas: failure of a primary chemotherapy approach.
    Kellie SJ; Boyce H; Dunkel IJ; Diez B; Rosenblum M; Brualdi L; Finlay JL
    Pediatr Blood Cancer; 2004 Aug; 43(2):126-33. PubMed ID: 15236278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
    Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA
    Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk-adapted chemotherapy of germ cell tumors with carboplatin, etoposide and bleomycin for low-risk and cisplatin, etoposide and ifosfamide for high-risk patients. A single-center study.
    Tscherry G; Jacky E; Jost LM; Stahel RA
    Oncology; 2000 Aug; 59(2):110-7. PubMed ID: 10971168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary chemotherapy for intracranial germ cell tumors: results of the third international CNS germ cell tumor study.
    da Silva NS; Cappellano AM; Diez B; Cavalheiro S; Gardner S; Wisoff J; Kellie S; Parker R; Garvin J; Finlay J
    Pediatr Blood Cancer; 2010 Mar; 54(3):377-83. PubMed ID: 20063410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation therapy for relapsed CNS germinoma after primary chemotherapy.
    Merchant TE; Davis BJ; Sheldon JM; Leibel SA
    J Clin Oncol; 1998 Jan; 16(1):204-9. PubMed ID: 9440744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity.
    Mann JR; Raafat F; Robinson K; Imeson J; Gornall P; Sokal M; Gray E; McKeever P; Hale J; Bailey S; Oakhill A
    J Clin Oncol; 2000 Nov; 18(22):3809-18. PubMed ID: 11078494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pediatric CNS tumors.
    Heideman RL; Kovnar EH; Kellie SJ; Douglass EC; Gajjar AJ; Walter AW; Langston JA; Jenkins JJ; Li Y; Greenwald C
    J Clin Oncol; 1995 Sep; 13(9):2247-54. PubMed ID: 7666082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors.
    Motzer RJ; Mazumdar M; Gulati SC; Bajorin DF; Lyn P; Vlamis V; Bosl GJ
    J Natl Cancer Inst; 1993 Nov; 85(22):1828-35. PubMed ID: 7693955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-radiation chemotherapy with response-based radiation therapy in children with central nervous system germ cell tumors: a report from the Children's Oncology Group.
    Kretschmar C; Kleinberg L; Greenberg M; Burger P; Holmes E; Wharam M
    Pediatr Blood Cancer; 2007 Mar; 48(3):285-91. PubMed ID: 16598761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction chemotherapy followed by reduced-volume radiation therapy for newly diagnosed central nervous system germinoma.
    Sawamura Y; Shirato H; Ikeda J; Tada M; Ishii N; Kato T; Abe H; Fujieda K
    J Neurosurg; 1998 Jan; 88(1):66-72. PubMed ID: 9420074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensity-modulated ventricular irradiation for intracranial germ-cell tumors: Survival analysis and impact of salvage re-irradiation.
    de Rezende ACP; Weltman E; Chen MJ; Helito JK; de Carvalho ÍT; Sakuraba RK; Silva NS; Cappellano AM; Hamerschlak N
    PLoS One; 2019; 14(12):e0226350. PubMed ID: 31860688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support.
    Margolin K; Doroshow JH; Ahn C; Hamasaki V; Leong L; Morgan R; Raschko J; Shibata S; Somlo G; Tetef M
    J Clin Oncol; 1996 Oct; 14(10):2631-7. PubMed ID: 8874321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity.
    Motzer RJ; Mazumdar M; Bosl GJ; Bajorin DF; Amsterdam A; Vlamis V
    J Clin Oncol; 1996 Apr; 14(4):1098-105. PubMed ID: 8648363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.
    Khatua S; Dhall G; O'Neil S; Jubran R; Villablanca JG; Marachelian A; Nastia A; Lavey R; Olch AJ; Gonzalez I; Gilles F; Nelson M; Panigrahy A; McComb G; Krieger M; Fan J; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2010 Jul; 55(1):42-6. PubMed ID: 20222020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children.
    Kellie SJ; Wong CK; Pozza LD; Waters KD; Lockwood L; Mauger DC; White L
    Med Pediatr Oncol; 2002 Sep; 39(3):168-74. PubMed ID: 12210445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapse and outcome patterns of patients with central nervous system mixed malignant germ cell tumors treated without irradiation: Findings from the third international central nervous system (CNS) germ cell tumor (GCT) study.
    Pruitt R; DaSilva NS; Cappellano A; Belessiotis C; Diez B; Gardner S; Allen J; Weinblatt M; Gottardo N; Dhall G; Finlay JL
    Pediatr Blood Cancer; 2015 Nov; 62(11):1920-4. PubMed ID: 26054044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996].
    Fléchon A; Biron P; Philip I; Blay JY; Droz JP
    Bull Cancer; 1999 Apr; 86(4):391-9. PubMed ID: 10341344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.